Patient info Open main menu

ATROGEL MUSCLE ACHES & PAINS ARNICA GEL - summary of medicine characteristics

Dostupné balení:

Summary of medicine characteristics - ATROGEL MUSCLE ACHES & PAINS ARNICA GEL

SUMMARY OF PRODUCT CHARACTERISTICS

1 NAME OF THE MEDICINAL PRODUCT

Atrogel Muscle Aches & Pains Arnica Gel

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

1 g gel contains:

500 mg extract (as liquid extract) of fresh Arnica Flowers (Arnica montana L.) (equivalent to 120 – 200 mg fresh Arnica Flowers)

Extractant: ethanol 58 %v/v

For a full list of excipients, see section 6.1

3 PHARMACEUTICAL FORM

Gel.

It is a slightly cloudy, golden-brown to green yellow coloured gel with a characteristic odour of Arnica.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

A traditional herbal medicinal product used for the symptomatic relief of muscular aches, pains and stiffness, sprains, bruises and swelling after contusions, exclusively based on long-standing use.

4.2 Posology and method of administration

Adults: Apply 2 – 10 cm gently to the affected area 2 to 4 times daily.

Children and the elderly: Apply similarly as described for adults (above).

For cutaneous use only.

4.3 Contraindications

Do not use in cases of known hypersensitivity to Arnica preparations, other members of the Asteraceae (Compositae) family, or one of the excipients.

4.4 Special warnings and precautions for use

Do not exceed the stated dose.

If the condition worsens, or if symptoms persist for more than two weeks, or if adverse events not mentioned in the package leaflet occur, consult a healthcare practitioner.

For cutaneous use only. Do not use on broken or irritated skin. Avoid contact with eyes and mucous membranes. Discontinue use if redness, irritation or dry skin occurs.

Keep out of the sight and reach of children.

4.5 Interaction with other medicinal products and other forms of interaction

None known.

4.6 Pregnancy and lactation

Pregnancy: There is no evidence of the safety of the product in human pregnancy, nor is there any evidence from animal studies. Although no adverse reactions have been observed, the use of the product during pregnancy should be avoided unless under the guidance of a medical practitioner.

Lactation: There is no evidence to suggest that the product should not be used during lactation.

4.7 Effects on ability to drive and use machines

Atrogel has no influence on the ability to drive and use machines.

4.8 Undesirable effects

Common (> 1/100 to < 1/10)

Skin and subcutaneous tissue disorders.

Contact dermatitis

Itching

Rash

Dry Skin

The incidence is reported in studies to be between 5 and 10% for Atrogel.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard

4.9 Overdose

4.9 Overdose

In case of overdose, irritation and redness may occur. Discontinue use.

In the unlikely event of internal ingestion, due to the irritant effect of Arnica, symptoms of intoxication may include gastro-intestinal and nervous system disturbances; dizziness, diarrhoea, shivering and palpitations. Respiratory difficulties may occur at very high doses. Treatment of overdose: the stomach should be emptied by aspiration or lavage if the patient has not already vomited. Demulcent drinks such as milk should be given.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Not applicable.

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

5.3 Preclinical safety data

Not applicable.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Ethanol (96 %)

Purified water

Glycerol (85 %)

Ammonium Acryloyldimet­hyltaurate/VP Copolymer

6.2 Incompati­bilities

Not applicable

6.3 Shelf life

3 years

Use within 6 months of opening. After opening, store below 25°C.

6.4 Special precautions for storage

This medicinal product does not require any special storage conditions.

For storage conditions after first opening, see section 6.3.

6.5 Nature and contents of container

Pack:        White laminated multilayer polyethylene tube with a vapour block

layer. The opening is sealed with an aluminium peel-seal.

Closure:      Polypropylene screw cap.

Pack size:    50 ml

100 ml

6.6 Special precautions for disposal

7   MARKETING AUTHORISATION HOLDER

8 REGISTRATION NUMBER(S

THR 13668/0009

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THEAUTHORISATION

30/10/2006